KR20210089345A - Manufacturing method of the Poria cocos Wolf extract - Google Patents
Manufacturing method of the Poria cocos Wolf extract Download PDFInfo
- Publication number
- KR20210089345A KR20210089345A KR1020200002398A KR20200002398A KR20210089345A KR 20210089345 A KR20210089345 A KR 20210089345A KR 1020200002398 A KR1020200002398 A KR 1020200002398A KR 20200002398 A KR20200002398 A KR 20200002398A KR 20210089345 A KR20210089345 A KR 20210089345A
- Authority
- KR
- South Korea
- Prior art keywords
- bokryeong
- extract
- present
- hours
- weight
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 51
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 241000282461 Canis lupus Species 0.000 title description 2
- 235000008599 Poria cocos Nutrition 0.000 title description 2
- 241001619444 Wolfiporia cocos Species 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 26
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 230000003579 anti-obesity Effects 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 13
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 3
- 238000007602 hot air drying Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 229920002498 Beta-glucan Polymers 0.000 abstract description 10
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract description 9
- 208000008589 Obesity Diseases 0.000 abstract description 4
- 229930003935 flavonoid Natural products 0.000 abstract description 4
- 150000002215 flavonoids Chemical class 0.000 abstract description 4
- 235000017173 flavonoids Nutrition 0.000 abstract description 4
- 235000020824 obesity Nutrition 0.000 abstract description 4
- 230000036542 oxidative stress Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 231100001083 no cytotoxicity Toxicity 0.000 abstract description 2
- 241001619454 Wolfiporia Species 0.000 abstract 5
- 239000000243 solution Substances 0.000 description 12
- 230000036541 health Effects 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- 238000000105 evaporative light scattering detection Methods 0.000 description 9
- 235000013376 functional food Nutrition 0.000 description 8
- 230000003712 anti-aging effect Effects 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 231100000135 cytotoxicity Toxicity 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 229920000310 Alpha glucan Polymers 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 150000003648 triterpenes Chemical class 0.000 description 4
- 241000408529 Libra Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000576755 Sclerotia Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- -1 U-pachyman Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000010421 standard material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108010022769 Glucan 1,3-beta-Glucosidase Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000008809 cell oxidative stress Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 108010046301 glucose peroxidase Proteins 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- FQZJYWMRQDKBQN-UHFFFAOYSA-N tricaine methanesulfonate Chemical compound CS([O-])(=O)=O.CCOC(=O)C1=CC=CC([NH3+])=C1 FQZJYWMRQDKBQN-UHFFFAOYSA-N 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
- A23L31/15—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Abstract
Description
본 발명은 복령 추출물의 제조방법 등에 관한 것이다. The present invention relates to a method for preparing a bokryeong extract and the like.
과학의 진보와 의료용 기술의 발달과 함께 인간 수명이 연장되면서 사람들의 건강에 대한 관심이 높아짐은 물론 마시는 물 등을 포함한 평소의 식습관에도 관심이 증대되고 있다.As human lifespan is extended along with advances in science and the development of medical technology, interest in people's health is increasing, as well as their daily eating habits, including drinking water.
복령(Wolfiporia cocos, syn. Poria cocos Wolf.)은 버섯류에 속하는 진균류의 일종으로 담자균 아강 다공균목 구멍버섯과 복령속으로, 죽은지 3~5년이 경과한 소나무류(Pinus spp.)의 뿌리 주변에 부정형의 균핵을 형성하는 기생균으로 알려져 있다. 복령의 균핵은 내부 색깔에 따라 육질이 견고한 백복령과 연하고 부드러운 적복령으로 구분되고, 동의보감에 의하면 복령은 우황청심환, 경옥고, 십전대보탕, 사물탕, 복령음가 반하탕, 사군자탕, 복령 보심탕을 비롯한 다양한 탕약에 약재로 이용될 수 있다. Bokryeong (Wolfiporia cocos, syn. Poria cocos Wolf.) is a kind of fungus belonging to the fungus family. It is known as a parasite that forms amorphous sclerotia around it. The sclerotia of Bokryeong are divided into white bokryeong with firm flesh and soft and tender jeokbokryeong according to the color of the inside. It can be used as medicine.
복령은 여러 종류의 triterpenes와 polysaccharides가 주성분이며 항암작용, 항산화작용, 살선충제, 항고지혈작용, 항세균작용, 항염증작용, 항고혈압작용, 면역증강 및 뇌세포 활성 등이 다양하게 알려져 있다. 특히 면역증강 및 뇌세포 활성 등의 생리활성도 알려져 있다. 복령의 성분 중에서 U-pachyman, pachymaran, carboxymethyl pachymarna, 그리고 (1,3)-(1,6)-β-D-glucan 등의 다당류는 항산화 효과가 뛰어나고, triterpenes 성분은 산화, 염증 및 췌장암에 효과가 있는 것으로 알려져 있다. 복령의 주요 약리성분으로는 β-glucan 및 triterpene, pachymaran 등이 있다. 약리성분 중 β-glucan과 triterpene은 생체조직재생, 치유기능, 항산화기능, 항균, 항염증, 항바이러스 등의 효과가 보고되어있고, pachymaran은 pachyman의 β-1,3-glucan에서 β-1,6분지를 가지지 않은 복령다당으로, pachyman은 자체 항종양 활성은 없지만 구조가 변하여 pachymaran이 되면 강력한 항암활성을 나타내는 것으로 보고되었으며, 복령은 혈중 트리글리세리드, 총 콜레스테롤, LDL- 콜레스테롤을 감소시키고, HDL+ 콜레스테롤을 증가시켜 혈중 지방 분포를 개선할 수 있음이 보고되어 있고, 복령균핵에서 분리한 4종의 항암 화합물이 폐선암의 암세포 증식을 억제해 암세포 자살을 유도하는 항암 효과를 갖고 있다는 연구결과가 보고되었다. 또한, 복령의 껍질 및 내피 추출물은 elastase와 collagenase 활성을 저해하여 주름 개선과 염증에 효능이 있어 화장품 천연 소재로 활용하고 있다.Bokryeong contains various kinds of triterpenes and polysaccharides as its main ingredients, and it is known for its anticancer action, antioxidant action, nematicide, antihyperlipidemic action, antibacterial action, anti-inflammatory action, antihypertensive action, immune enhancement and brain cell activity. In particular, physiological activities such as immune enhancement and brain cell activity are known. Among the components of bokryeong, polysaccharides such as U-pachyman, pachymaran, carboxymethyl pachymarna, and (1,3)-(1,6)-β-D-glucan have excellent antioxidant effects, and triterpenes components have effects on oxidation, inflammation and pancreatic cancer. is known to have The main pharmacological components of bokryeong include β-glucan, triterpene, and pachymaran. Among the pharmacological components, β-glucan and triterpene have been reported to have biological tissue regeneration, healing function, antioxidant function, antibacterial, anti-inflammatory, and antiviral effects. As a bokryeong polysaccharide without 6 branches, pachyman has no antitumor activity, but it has been reported to exhibit strong anticancer activity when the structure is changed to pachymaran. Bokryeong reduces blood triglycerides, total cholesterol, LDL- cholesterol, and lowers HDL+ cholesterol. It has been reported that it can improve blood fat distribution by increasing it, and research results have been reported that 4 types of anticancer compounds isolated from bokryeong sclerotia have an anticancer effect that induces cancer cell suicide by inhibiting cancer cell proliferation in lung adenocarcinoma. In addition, bokryeong bark and endothelial extracts inhibit elastase and collagenase activity and are effective in wrinkle improvement and inflammation, so they are used as natural cosmetic materials.
복령의 다양한 효능은 여러 분야에서 그 사용량이 매년 증가되어 중국으로부터 수입량이 증가 하고 있다. 특히 식품의약품안전처의 식품의약품통계연보에 따르면 2015년 기준 국내 약재 생산량 10위 수입량 7위, 수입 수량으로는 2위로 한약재중 감초 다음으로 많이 사용되고 있지만 국내산 복령은 소나무 벌목금지 조례로 원목 공급이 한정적이라 국내 복령 재배 농가가 거의 없어 90%이상이 자연산으로 공급이 한정적이므로 수입산 복령에 비해 가격이 높게 책정되어 있다.Due to the various effects of bokryeong, its use in various fields is increasing every year, and the amount of imports from China is increasing. In particular, according to the Food and Drug Statistical Yearbook of the Ministry of Food and Drug Safety, as of 2015, it ranked 10th in domestic drug production, 7th in import volume, and 2nd in import volume, and is the second most used herbal medicine after licorice. Because there are few domestic bokryeong farms, more than 90% of it is natural, and the supply is limited, so the price is set higher than that of imported bokryeong.
한약재로서 복령은 탕을 끓이거나, 우려내는 방식으로 이용되어 왔다. 그러나, 복령의 약리적 효능을 극대화할 수 있는 추출방법에 대해서는 아직 부족한 실정이다. 이에, 복령의 기능성 식품, 의약품, 의약외품으로의 이용가능성을 확대하고자 본 발명자들은 인체에 무해하고 그 효능을 향상시킬 수 있는 복령 추출물 제조방법을 예의 연구하여 본 발명을 완성하였다. As a herbal medicine, bokryeong has been used to boil or brew soup. However, there is still a lack of an extraction method that can maximize the pharmacological efficacy of bokryeong. Accordingly, in order to expand the usability of bokryeong as functional food, medicine, and quasi-drugs, the present inventors have completed the present invention by intensively researching a method for preparing bokryeong extract that is harmless to the human body and can improve its efficacy.
본 발명이 이루고자 하는 기술적 과제는 진공저온추출법을 이용한 복령 추출물의 제조방법을 제공하고, 상기 방법에 의해 제조된 복령 추추물을 포함하는 항비만, 항노화, 및/또는 항산화용 식품 조성물을 제공하는 것이다.The technical problem to be achieved by the present invention is to provide a method for preparing a bokryeong extract using a vacuum low temperature extraction method, and to provide a food composition for anti-obesity, anti-aging, and/or antioxidant comprising the bokryeong extract prepared by the method will be.
그러나 본 발명이 이루고자 하는 기술적 과제는 이상에서 언급한 과제에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당해 기술분야의 통상의 기술자에게 명확하게 이해될 수 있을 것이다.However, the technical problem to be achieved by the present invention is not limited to the above-mentioned problems, and other problems not mentioned will be clearly understood by those skilled in the art from the following description.
상기 과제를 해결하기 위하여, 본 발명은 진공저온추출법을 이용한 복령 추출물 제조방법을 제공한다.In order to solve the above problems, the present invention provides a method for preparing a bokryeong extract using a vacuum low temperature extraction method.
본 발명의 제조방법은 구체적으로 하기 단계를 포함한다:The preparation method of the present invention specifically comprises the following steps:
(1) 복령을 세척 후 건조하는 단계; (2) 상기 건조된 복령을 파쇄하는 단계; (3) 상기 파쇄된 복령을 35~45 ℃에서 10 내지 14 시간 동안 열풍 건조하는 단계; (4) 상기 열풍 건조된 복령 1 중량부 기준으로 8~12 중량부의 증류수를 혼합하는 단계; 및 (5) 상기 증류수와 혼합된 복령을 75~85 ℃에서 10 내지 14 시간 동안 진공저온 추출하는 단계.(1) washing and drying bokryeong; (2) crushing the dried bokryeong; (3) drying the crushed bokryeong with hot air at 35 to 45° C. for 10 to 14 hours; (4) mixing 8 to 12 parts by weight of distilled water based on 1 part by weight of the hot air dried bokryeong; and (5) extracting bokryeong mixed with the distilled water at 75-85° C. for 10 to 14 hours under vacuum.
본 발명의 일 구현예로서, 상기 (3) 단계의 열풍 건조는 40 ℃에서 12시간 동안 수행될 수 있다. As an embodiment of the present invention, the hot air drying in step (3) may be performed at 40° C. for 12 hours.
본 발명의 다른 구현예로서, 상기 (4) 단계는 열풍 건조된 복령 1 중량부 기준으로 10 중량부의 증류수를 혼합할 수 있다. As another embodiment of the present invention, in step (4), 10 parts by weight of distilled water may be mixed based on 1 part by weight of hot-air dried bokryeong.
본 발명의 또 다른 구현예로서, 상기 (5) 단계의 진공저온 추출은 80 ℃에서 12시간 동안 수행될 수 있다. As another embodiment of the present invention, the vacuum low temperature extraction of step (5) may be performed at 80 °C for 12 hours.
또한, 본 발명은 상기 방법으로 제조되어 세포 독성이 없는 복령 추출물을 제공한다. In addition, the present invention provides a bokryeong extract prepared by the above method without cytotoxicity.
또한, 본 발명은 상기 복령 추출물을 포함하는 비만 예방 또는 개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for preventing or improving obesity comprising the extract of bokryeong.
또한, 본 발명은 상기 복령 추출물을 포함하는 항노화 또는 항산화용 식품 조성물을 제공한다. In addition, the present invention provides a food composition for anti-aging or antioxidant comprising the extract of bokryeong.
본 발명의 일 구현예로서 상기 항노화는 산화적 스트레스에 의한 세포 또는 세포 외 기질의 손상을 의미한다. As an embodiment of the present invention, the anti-aging means damage to cells or extracellular matrix caused by oxidative stress.
본 발명의 복령 추출물 제조방법은 추출 수율을 크게 향상시켜 플라보노이드 함량이 매우 높은 추출물을 제조할 수 있으며, 또한, 본 발명의 방법으로 제조된 복령 추출물은 세포 독성이 거의 없고, 항비만 및 항산화 효과에 있어서도 현저하게 우수한 활성을 나타내는바, 비만 및 산화적 스트레스 예방 또는 개선을 위한 식품에 이용될 수 있다. 또한, 본 발명의 방법으로 제조된 복령 추출물은 베타글루칸의 함량이 보다 높게 유지되는 바 복령의 섭취로 인한 면역 증강 효과를 보다 강화시킬 수 있다. The bokryeong extract preparation method of the present invention can greatly improve the extraction yield to produce an extract having a very high flavonoid content. Also, the bokryeong extract prepared by the method of the present invention has almost no cytotoxicity, and has anti-obesity and antioxidant effects. It also exhibits a remarkably excellent activity in the bar, it can be used in food for preventing or improving obesity and oxidative stress. In addition, the bokryeong extract prepared by the method of the present invention can further strengthen the immune enhancing effect due to the intake of bokryeong bar content of beta-glucan is maintained higher.
도 1은 본 발명의 복령 추출물 제조 방법의 모식도 이다.
도 2는 본 발명의 제조방법에 의해 제조된 복령 추출물의 세포독성을 나타내는 그래프이다.
도 3은 본 발명의 제조방법에 의해 제조된 복령 추출물의 총 플라보노이드 함량을 나타낸 그래프이다.
도 4는 본 발명의 제조방법에 의해 제조된 복령 추출물의 항산화능을 확인한 그래프이다.
도 5는 본 발명의 제조방법에 의해 제조된 복령 추출물 투여에 따른 제브라피쉬 의 혈당 변화를 나타낸 그래프이다.
도 6은 본 발명의 제조방법에 의해 제조된 복령 추출물 투여에 따른 제브라피쉬의 BMI 변화를 나타낸 그래프이다.
도 7은 본 발명의 제조방법에 의해 제조된 복령 추출물의 당 성분을 분석한 결과이다.
도 8은 본 발명의 제조방법에 의해 제조된 복령 추출물의 UPLC 성분 분석 결과이다.
도 9는 본 발명의 제조방법에 의해 제조된 복령 추출물의 베타글루칸 함량을 나타낸 그래프이다.1 is a schematic diagram of a method for preparing a bokryeong extract of the present invention.
Figure 2 is a graph showing the cytotoxicity of the extract prepared by the production method of the present invention.
Figure 3 is a graph showing the total flavonoid content of the extract prepared by the method of the present invention.
Figure 4 is a graph confirming the antioxidant activity of the extract prepared by the method of the present invention.
5 is a graph showing changes in blood sugar of zebrafish according to administration of a bokryeong extract prepared by the method of the present invention.
6 is a graph showing the change in BMI of zebrafish according to the administration of the extract prepared by the method of the present invention.
7 is a result of analyzing the sugar component of the extract prepared by the method of the present invention.
8 is a UPLC component analysis result of a bokryeong extract prepared by the method of the present invention.
9 is a graph showing the beta-glucan content of the extract prepared by the method of the present invention.
본 발명은 복령의 진공저온농축 열수추출물에 관한 것으로서, 복령피를 포함하는복령을 진공저온농축법으로 추출함으로서 복령의 생리유용물질을 다량함유하고 인체에 무해한 복령 추출물을 제공할 수 있다. The present invention relates to a vacuum low temperature concentrated hot water extract of bokryeong, and by extracting bokryeong containing bokryeong blood by vacuum low temperature concentration method, bokryeong extract containing a large amount of physiologically useful substances of bokryeong and harmless to the human body can be provided.
본 발명의 방법으로 제조된 복령 추출물은 세포독성이 없거나 매우 낮아 인체에 무해하고, 항산화, 항비만, 및 면역 증강에 우수한 효과를 나타내는바 식품에 포함되어 국민건강 증진에 도움이 될 수 있고, 상기 식품은 기능성 식품 및 건강기능성 식품을 포함한다.The bokryeong extract prepared by the method of the present invention has no or very low cytotoxicity, is harmless to the human body, and has excellent effects on antioxidant, anti-obesity, and immune enhancement. Food includes functional food and health functional food.
본 발명의 제조방법은 복령의 추출 수율이 70% 이상의 것으로서, 보다 구체적으로 그 추출 수율은 70~85% 이다. In the manufacturing method of the present invention, the extraction yield of bokryeong is 70% or more, and more specifically, the extraction yield is 70-85%.
한편, 본 발명의 복령 추출물 제조방법에서 이용되는 복령은 복령피를 포함하는 것이 바람직하고, 비매립 인공재배된 반년생 이상의 복령일 수 있다. On the other hand, the bokryeong used in the preparation method of the bokryeong extract of the present invention preferably includes bokryeongpi, and may be non-reclaimed artificially cultivated bokryeong more than half a year old.
본 발명의 복령 추출물 제조방법은 비매립 인공재배된 복령을 30분 동안 세척하고 표면의 수분을 제거한 후 잘게 파쇄한다. 이어서 파쇄된 상기 복령을 40℃에서 12시간 열풍 건조하고, 건조된 복령 무게의 10배에 해당하는 멸균된 정제수를 첨가하여 80℃에서 12시간 동안 냉각을 해주며 진공저온농축 추출을 통해 제조하였다. The bokryeong extract manufacturing method of the present invention is to wash the non-reclaimed artificially cultivated bokryeong for 30 minutes, remove the surface moisture, and then crush it finely. Then, the crushed bokryeong was dried with hot air at 40° C. for 12 hours, and sterilized purified water corresponding to 10 times the weight of the dried bokryeong was added, cooled at 80° C. for 12 hours, and vacuum low temperature concentration extraction was performed.
제조된 복령 추출물의 당 성분의 확인을 위하여 HPLC-ELSD를 수행한 결과는 하기 표 1과 같다. The results of performing HPLC-ELSD to confirm the sugar components of the prepared bokryeong extract are shown in Table 1 below.
한편, 상기 제조된 추출물은 이후 여과하거나 농축 또는 건조과정을 수행하여 용매를 제거할 수 있으며, 여과, 농축 및 건조를 모두 수행할 수 있다. 예컨대, 여과는 여과지를 이용하거나 감압여과기를 이용할 수 있으나, 상기 여과지는 Grade 1 여과지를 이용하는 것이 바람직하다. 또한, 상기 농축은 감압 농축기, 건조는 분무 건조법, 동결건조법 등을 수행할 수 있으나, 이것으로 제한되는 것은 아니다.On the other hand, the prepared extract may then be filtered or concentrated or dried to remove the solvent, and both filtration, concentration and drying may be performed. For example, the filtration may use a filter paper or a reduced pressure filter, but the filter paper is preferably a
본 발명의 방법으로 제조된 복령 추출물은 항산화 및 항비만 효과에 있어서 다른 유기용매를 이용한 추출물보다 우수한 활성을 나타내고, MTT assay 에서 낮은 세포 독성을 나타내었는바 항비만, 항노화, 및/또는 항산화를 위한 건강기능식품에 포함될 수 있다. 상기 항노화는 활성산소에 의한 노화를 의미하고, 본 발명의 복령 추출물은 산화적 스트레스로 야기되는 세포 노화를 예방 또는 개선할 수 있다. Bokryeong extract prepared by the method of the present invention exhibited superior activity than extracts using other organic solvents in antioxidant and anti-obesity effects, and showed low cytotoxicity in MTT assay, anti-obesity, anti-aging, and/or anti-oxidation. It can be included in health functional food for The anti-aging means aging by free radicals, and the bokryeong extract of the present invention can prevent or improve cellular aging caused by oxidative stress.
이에, 본 발명은 복령 추출물을 유효성분으로 포함하는 비만 또는 세포의 산화적 스트레스 예방 또는 개선을 위한 건강기능식품 조성물을 제공할 수 있으며, 보다 구체적으로, 본 발명의 조성물은 항비만, 항노화, 및/또는 항산화를 목적으로 건강기능식품에 첨가될 수 있으며, 본 발명의 항비만, 항노화, 및/또는 항산화 효과를 갖는 복령추출물을 식품 첨가물로 사용할 경우, 상기 추출물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용할 수 있고, 통상적인 방법에 따라 적절하게 사용할 수 있다. 유효성분의 혼합양은 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조 시 본 발명의 화합물은 원료에 대하여 15 중량% 이하, 바람직하게는 10 중량% 이하의 양으로 첨가된다. 그러나 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.Therefore, the present invention can provide a health functional food composition for preventing or improving obesity or cellular oxidative stress comprising the extract of bokryeong as an active ingredient, and more specifically, the composition of the present invention is anti-obesity, anti-aging, And/or it may be added to health functional food for the purpose of antioxidant, and when the bokryeong extract having an anti-obesity, anti-aging, and/or antioxidant effect of the present invention is used as a food additive, the extract may be added as it is or other food or It can be used together with food ingredients, and can be used appropriately according to a conventional method. The mixed amount of the active ingredient may be appropriately determined according to the purpose of use (prevention, health or therapeutic treatment). In general, in the production of food or beverage, the compound of the present invention is added in an amount of 15% by weight or less, preferably 10% by weight or less, based on the raw material. However, in the case of long-term ingestion for health and hygiene purposes or for health control, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강기능식품을 모두 포함한다.There is no particular limitation on the type of the food. Examples of foods to which the above substance can be added include meat, sausage, bread, chocolate, candies, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, beverages, tea, drinks, There are alcoholic beverages and vitamin complexes, and includes all health functional foods in the ordinary sense.
본 발명의 건강음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당 및 과당과 같은 모노사카라이드, 말토오스 및 수크로오스와 같은 디사카라이드, 덱스트린 및 시클로덱스트린과 같은 폴리사카라이드, 및 자일리톨, 소르비톨 및 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100㎖당 일반적으로 약 0.01 내지 0.20g, 바람직하게는 약 0.04 내지 0.10g 이다.The health beverage composition of the present invention may contain various flavoring agents or natural carbohydrates as an additional component like a conventional beverage. The above-mentioned natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. As the sweetener, natural sweeteners such as taumatine and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like can be used. The proportion of the natural carbohydrate is generally about 0.01 to 0.20 g, preferably about 0.04 to 0.10 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0.01 내지 0.20 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition of the present invention includes various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, It may contain a carbonation agent used in carbonated beverages, and the like. In addition, the composition of the present invention may contain fruit for the production of natural fruit juice, fruit juice beverage, and vegetable beverage. These components may be used independently or in combination. The proportion of these additives is not critical, but is generally selected in the range of 0.01 to 0.20 parts by weight per 100 parts by weight of the composition of the present invention.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 이하 특정 실시예들을 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.The present invention can apply various transformations and can have various embodiments. Hereinafter, specific embodiments are illustrated in the drawings and described in detail in the detailed description. However, this is not intended to limit the present invention to specific embodiments, and it should be understood to include all modifications, equivalents and substitutes included in the spirit and scope of the present invention. In describing the present invention, if it is determined that a detailed description of a related known technology may obscure the gist of the present invention, the detailed description thereof will be omitted.
[실시예][Example]
실시예 1. 세포 독성 확인Example 1. Confirmation of cytotoxicity
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) 시약을 제조하기 위하여 2 mg/mL의 농도에 맞추어 PBS로 희석하였다.To prepare MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) reagent, it was diluted with PBS to a concentration of 2 mg/mL.
시약이 PBS에 잘 녹지 않으므로 30분 sonication하였고, 완전히 녹으면 0.2 μM로 filtering하여 사용하였다. MTT 시약은 빛에 약하므로 호일을 씌어 빛을 차단하여 보관하였다.Since the reagent does not dissolve well in PBS, it was sonicated for 30 minutes. When completely dissolved, it was used by filtering with 0.2 μM. Since MTT reagent is weak to light, it was stored by covering it with foil to block the light.
저온진공농축 열수추출법으로 추출된 복령 추출물을 96 well plate에 RAW264.7 cell을 2.0 × 10 cell/well이 되도록 동일하게 분주하고 18시간 동안 전 배양 하였다.The bokryeong extract extracted by low temperature vacuum concentration hot water extraction method was equally aliquoted to 2.0 × 10 cells/well of RAW264.7 cells in a 96 well plate and pre-cultured for 18 hours.
기존의 배지를 제거하고, 새 배지 및 농도에 따른 시료를 처리하여 다시 24시간 동안 배양하였다. MTT 시약을 새 배지에 희석하여 호일로 감싸두었다.The old medium was removed, and the sample according to the new medium and concentration was treated and incubated for 24 hours again. MTT reagent was diluted in fresh medium and wrapped in foil.
well에 있는 배지를 제거한 후, MTT 시약을 100 μL씩 처리하였다. 시약 처리 후 37℃에서 3~4시간 incubation 하였다. After removing the medium in the well, 100 μL of MTT reagent was treated. After reagent treatment, incubation was performed at 37°C for 3-4 hours.
MTT 시약을 제거한 후 DMSO를 well당 100μL씩 넣어주었다. DMSO에 formazan이 골고루 녹아 보라색으로 발색될 수 있도록 하였다. 540 nm에서 흡광도를 측정하였다.After removing the MTT reagent, 100 μL of DMSO was added per well. Formazan was uniformly dissolved in DMSO to develop purple color. Absorbance was measured at 540 nm.
샘플의 MTT 측정 시험 결과는 도 2 에 나타내었다. 시료를 처리하지 않은 대조군의 세포 생존능력을 100%로 보았을 때, 열수추출물을 처리한 군에서 세포에 대한 독성을 나타내지 않았다. 반면 에탄올추출물을 처리한 원액군에서 40% 생존율 억제를 보였고, 1/2희석군, 1/4희석군, 1/8희석군에서 또한 세포 생존율 억제를 나타내는 것을 확인하였다. The MTT measurement test result of the sample is shown in FIG. 2 . When the cell viability of the control group not treated with the sample was 100%, the group treated with the hot water extract showed no toxicity to the cells. On the other hand, the ethanol extract-treated stock solution group showed 40% survival rate inhibition, and it was confirmed that the 1/2 dilution group, 1/4 dilution group, and 1/8 dilution group also showed inhibition of cell viability.
세포독성 실험에서 인체에 무해하기 위하여, 주정추출법을 포함한 유기용매를 이용한 추출법은 복령을 식품 가공품, 음료, 차, 약물의 조성물로 사용하기에 안전하지 않을 것으로 사료된다. In order to be harmless to the human body in the cytotoxicity test, it is considered that the extraction method using organic solvents, including the alcohol extraction method, is not safe to use as a composition of food processing products, beverages, tea, and drugs.
실시예 2. 총 플라보노이드 함량 측정Example 2. Determination of total flavonoid content
시험관에 표준물질 또는 시험물질 200 μL와 초순수 800 μL를 넣는다. Add 200 µL of standard or test substance and 800 µL of ultrapure water to the test tube.
여기에 5% NaNO2 (w/v)용액을 60 μL를 첨가한다.Add 60 μL of 5% NaNO2 (w/v) solution here.
10% AICI3 (w/v)용액을 60 μL 첨가한 후 5분간 반응시킨다.After adding 60 μL of 10% AICI3 (w/v) solution, react for 5 minutes.
1M NaOH용액을 400 μL와 deionized water 480 μL를 넣고, 6 분간 반응시킨다.Add 400 μL of 1M NaOH solution and 480 μL of deionized water, and react for 6 minutes.
UV-Vis spectrophotometer (Libra S70, Biochrom, UK)를 이용하여 510 nm 에서 흡광도를 측정한다.Absorbance is measured at 510 nm using a UV-Vis spectrophotometer (Libra S70, Biochrom, UK).
표준물질 quercetin 을 이용하여 표준물질의 검량선을 작성하고, 시료의 흡광도를 검량선에 적용하여 QE mg/100 mL extract 로 표기하였다.A calibration curve of the standard material was prepared using the standard material quercetin, and the absorbance of the sample was applied to the calibration curve and expressed as QE mg/100 mL extract.
실시예 3. DPPH 라디컬 소거능 측정Example 3. Measurement of DPPH radical scavenging ability
DPPH시약 24 mg 을 methanol 100 mL 에 녹인 후, -20°C에서 보관하였다.After dissolving 24 mg of DPPH reagent in 100 mL of methanol, it was stored at -20°C.
보관한 DPPH 용액은 사용하기 전에 O.D. 0.98±0.02으로 조정하여 사용하였다Stored DPPH solution should be O.D. It was used by adjusting it to 0.98±0.02.
시료 50 μL 에 DPPH 용액 1.5 mL 을 가하고 30분간 암소에서 반응하였다.1.5 mL of DPPH solution was added to 50 μL of sample and reacted in the dark for 30 minutes.
UV-Vis spectrophotometer (Libra S70, Biochrom, UK)를 이용하여 517 nm 에서 흡광도를 측정하였다.Absorbance was measured at 517 nm using a UV-Vis spectrophotometer (Libra S70, Biochrom, UK).
실시예 4. ABTs assay 측정Example 4. ABTs assay measurement
7 mM ABTS 용액을 2.45 mM potassium persulfate (final concentration)과 혼합하여 실온의 암소에서 12-16시간 반응시켜 ABTS radical cation (ABTS·+)을 생성시켰다. ABTS radical cation (ABTS·+) was generated by mixing 7 mM ABTS solution with 2.45 mM potassium persulfate (final concentration) and reacting for 12-16 hours in a dark place at room temperature.
ABTS·+ 용액은 사용하기 전에 ethanol 을 이용하여, 734nm 에서 흡광도 0.70 (±0.02)으로 조정하여 사용하였다. The ABTS·+ solution was used by adjusting the absorbance to 0.70 (±0.02) at 734 nm by using ethanol before use.
시료 10 μL에 ABTS 용액 1.0 mL을 가하고 15분간 30 ℃ 암소에서 반응하였다. 1.0 mL of ABTS solution was added to 10 μL of the sample and reacted at 30 °C in a dark place for 15 minutes.
UV-Vis spectrophotometer (Libra S70, Biochrom, UK)를 이용하여 734 nm 에서 흡광도를 측정하였다. Absorbance was measured at 734 nm using a UV-Vis spectrophotometer (Libra S70, Biochrom, UK).
실시예 5. 항비만 효과 BMI 및 혈당 측정Example 5. Anti-obesity effect BMI and blood glucose measurement
실험에 적용될 개체들은 각 1마리씩(총 40마리) 수조(수온 26-28.5℃, pH 6.8-7.5)에서 사육하였으며, 일반사료와 복령혼합사료를 동량 급여하여 주었다.Individuals to be subjected to the experiment were bred in a water tank (water temperature 26-28.5℃, pH 6.8-7.5), one each (total of 40), and fed the same amount of general feed and bokryeong mixed feed.
일반사료와 복령혼합사료를 급여할 개체를 구분하여 각 수조(수온 26-28.5℃, pH 6.8-7.5에서 사육하였으며, 약 2개월간 두 종류의 사료를 각각 급여하였다.Individuals to be fed general feed and bokryeong mixed feed were separated and bred in each water tank (water temperature 26-28.5℃, pH 6.8-7.5), and two types of feed were fed each for about 2 months.
각 수조에 일반사료 또는 복령혼합사료를 일 3회 급여하였다.General feed or bokryeong mixed feed was fed to each tank 3 times a day.
매일 Total Length, Weight를 측정하였다.Total length and weight were measured daily.
측정한 Length, Weight를 이용해 BMI 지수를 계산하고, 2개월 관찰 측정하였다.The BMI index was calculated using the measured length and weight, and observation was performed for 2 months.
측정 시에 Ethyl 3- aminobenzoate methanesulfonate(98%, Sigma, E10521-10G) 0.2% stock을 만들어 사용하였다.During the measurement, 0.2% stock of Ethyl 3-aminobenzoate methanesulfonate (98%, Sigma, E10521-10G) was prepared and used.
실시예 5. 베타글루칸 함량 측정Example 5. Beta glucan content measurement
복령의 베타글루칸 함량 측정은 megazyme kit (mushroom and yeast β-glucan assay procedure kit)를 사용 하여 측정하였다. The beta-glucan content of bokryeong was measured using a megazyme kit (mushroom and yeast β-glucan assay procedure kit).
동결건조된 시료 100mg에 37% HCl 1.5 mL를 넣고 30℃ 물중탕에서 45min 교반한 후, 3차 증류수 10 mL를 가하고 100℃ 물중탕에서 다시 2시간 동안 교반하였다.To 100 mg of the freeze-dried sample, 1.5 mL of 37% HCl was added, stirred in a water bath at 30°C for 45 min, and then 10 mL of tertiary distilled water was added, followed by stirring in a water bath at 100°C for another 2 hours.
반응 액을 상온에서 2N-KOH 10mL를 가하여 혼합한 후 0.2 M 아 세트산소듐 완충용액(sodium acetate buffer, pH 5.0)을 가하여 100 mL로 정용하였다. At room temperature, 10 mL of 2N-KOH was added and mixed to the reaction solution, and 0.2 M sodium acetate buffer (pH 5.0) was added thereto to make 100 mL.
정용한 시료는 원심분리(2,000 g, 5min)하 여 상층액을 얻고, 얻은 상층액 0.1mL에 외부 1,3-베타글루칸 가수분해효소(exo-1,3-β-glucanase) 20U/mL와 베타글루코시데이 (β-glucosidase) 4 U/mL 혼합 용액 0.1 mL를 첨가한 후 40℃물 중탕에서 1h 반응하였다. The refined sample was centrifuged (2,000 g, 5 min) to obtain a supernatant, and in 0.1 mL of the obtained supernatant, 20 U/mL of external 1,3-beta-glucanase (exo-1,3-β-glucanase) After adding 0.1 mL of a 4 U/mL mixed solution of glucosidase (β-glucosidase), it was reacted for 1 h in a water bath at 40°C.
반응액에 포도당 산화효소/과산 화효소(glucose oxidase/peroxidase, GOPOD) 시약 3mL를 넣고 20분간 반응 후 510nm 파장에서 흡광도를 측정하여 총 글루칸 함량을 구하였다. 3 mL of glucose oxidase/peroxidase (GOPOD) reagent was added to the reaction solution, and after 20 minutes of reaction, absorbance was measured at a wavelength of 510 nm to determine the total glucan content.
알파글루칸(α-glucan) 함량을 구하였다. Alpha glucan (α-glucan) content was obtained.
총 글루칸(total glucan)과 알파글루칸의 흡광도는 표준물질인 포도당(glucose) 용액을 GOPOD 시약과 반응시킨 반응액의 흡광도를 이용하여 mg/100g값으로 계산하였다. The absorbance of total glucan and alpha glucan was calculated as mg/100g value using the absorbance of a reaction solution in which a standard material, a glucose solution, was reacted with a GOPOD reagent.
베타글루칸 함량은 총 글루칸 함량에서 알파글루칸 함량을 빼준 값으로 계산하였다.The beta-glucan content was calculated by subtracting the alpha-glucan content from the total glucan content.
그 결과는 아래와 같다. The result is as follows.
Total glucan 7.2±0.91 - a glucan 2.7±1.18 = b glucan 4.5±0.77 (mg/g)Total glucan 7.2±0.91 - a glucan 2.7±1.18 = b glucan 4.5±0.77 (mg/g)
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.As described above in detail a specific part of the present invention, for those of ordinary skill in the art, it is clear that this specific description is only a preferred embodiment, and the scope of the present invention is not limited thereby. something to do. Accordingly, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Claims (6)
(2) 상기 건조된 복령을 파쇄하는 단계;
(3) 상기 파쇄된 복령을 35~45 ℃에서 10 내지 14 시간 동안 열풍 건조하는 단계;
(4) 상기 열풍 건조된 복령 1 중량부 기준으로 8~12 중량부의 증류수를 혼합하는 단계; 및
(5) 상기 증류수와 혼합된 복령을 75~85 ℃에서 10 내지 14 시간 동안 진공저온 추출하는 단계;를 포함하는 복령 추출물 제조방법.
(1) washing and drying bokryeong;
(2) crushing the dried bokryeong;
(3) drying the crushed bokryeong with hot air at 35 to 45° C. for 10 to 14 hours;
(4) mixing 8 to 12 parts by weight of distilled water based on 1 part by weight of the hot air dried bokryeong; and
(5) extracting bokryeong mixed with the distilled water at 75-85 ℃ for 10 to 14 hours at a vacuum low temperature; a method for preparing bokryeong extract comprising.
상기 (3) 단계의 열풍 건조는 40 ℃에서 12시간 동안 수행되는 것을 특징으로 하는, 복령 추출물 제조방법.
According to claim 1,
The hot air drying of step (3) is characterized in that it is carried out at 40 ℃ for 12 hours, Bokryeong extract preparation method.
상기 (4) 단계는 열풍 건조된 복령 1 중량부 기준으로 10 중량부의 증류수를 혼합하는 것을 특징으로 하는, 복령 추출물 제조방법.
According to claim 1,
In step (4), 10 parts by weight of distilled water based on 1 part by weight of hot-air dried bokryeong is mixed, the bokryeong extract manufacturing method.
상기 (5) 단계의 진공저온 추출은 80 ℃에서 12시간 동안 수행되는 것을 특징으로 하는, 복령 추출물 제조방법.
According to claim 1,
The vacuum low temperature extraction of step (5) is characterized in that performed at 80 ℃ for 12 hours, Bokryeong extract preparation method.
An antioxidant composition comprising the extract of bokryeong prepared by any one of claims 1 to 4 as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200002398A KR20210089345A (en) | 2020-01-08 | 2020-01-08 | Manufacturing method of the Poria cocos Wolf extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200002398A KR20210089345A (en) | 2020-01-08 | 2020-01-08 | Manufacturing method of the Poria cocos Wolf extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210089345A true KR20210089345A (en) | 2021-07-16 |
Family
ID=77150856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200002398A KR20210089345A (en) | 2020-01-08 | 2020-01-08 | Manufacturing method of the Poria cocos Wolf extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210089345A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115176890A (en) * | 2022-06-29 | 2022-10-14 | 瑞普高科(天津)生物技术有限公司 | Application of poria beta-1,3-D-glucan in preparation of feed additive for improving growth performance |
-
2020
- 2020-01-08 KR KR1020200002398A patent/KR20210089345A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115176890A (en) * | 2022-06-29 | 2022-10-14 | 瑞普高科(天津)生物技术有限公司 | Application of poria beta-1,3-D-glucan in preparation of feed additive for improving growth performance |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rashwan et al. | Jujube fruit: A potential nutritious fruit for the development of functional food products | |
Suganya et al. | Pharmacological importance of sulphated polysaccharide carrageenan from red seaweed Kappaphycus alvarezii in comparison with commercial carrageenan | |
KR101936294B1 (en) | Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata | |
KR101292837B1 (en) | Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient | |
KR20180040534A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR101182032B1 (en) | Composition comprising the essential oil extract of Laminaria japonica showing anti-oxidant activity | |
KR102236071B1 (en) | Composition for Improving Skin Trouble Using an Extract of Centella asiatica or Paeonia lactiflora Cultured with Magma Seawater | |
KR20210089345A (en) | Manufacturing method of the Poria cocos Wolf extract | |
KR101474998B1 (en) | Composition comprising extracts of white tea for the care of skin wrinkle | |
KR20110054747A (en) | A composition for skin wrinkle improvement comprising extracts or fractions of eremochloa ophiuroides as an active ingredient | |
KR100802005B1 (en) | Melanin Biosynthesis Inhibitors which using of ginsenosides | |
KR20230121549A (en) | Composition for improving skin comprising steamed citrus peel extracts as an active ingredient | |
CN109549036A (en) | A kind of composite juice and preparation method thereof of collaboration fructus lycii effect | |
KR102271861B1 (en) | Food composition for skin improvement with natural material extracts | |
KR20170077980A (en) | Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill. | |
KR101939151B1 (en) | Composition for preventing, improving or treating metabolic diseases comprising plasma-treated phloridzin as effective component | |
KR20110049577A (en) | Composition comprising the essential oil extract of hizikia fusiforme showing anti-oxidant activity | |
KR102216618B1 (en) | Fermentation method of lactic acid bacteria using artichoke and its use | |
KR102590758B1 (en) | Antioxidant or anti-inflammatory composition comprising extract of bilberry containing anthocyanidin components | |
KR20190070569A (en) | Composition for anti-oxidant, skin whitening and anti-wrinkle effect comprising Glehnia Radix leaf extract as effective component | |
KR102659269B1 (en) | Tetragonia tetragonioides extract showing whitening and anti-inflammatory activity | |
KR102431762B1 (en) | Chaga extract enhanced active ingredients and preparation m ethod of the same including two step extraction process with high-temperature pressurization | |
KR102606796B1 (en) | Composition for Improving Skin Wrinkles and Whiteninig Skin Using an Extract of Pyrus calleryana | |
KR102556146B1 (en) | Compositions for Skin Moisturizing Using an Extract of Malus sieboldii | |
KR102247330B1 (en) | Compositions for Improving Skin Wrinkles and Anti-oxidative Composition Using an Extract of Bistorta manshuriensis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |